TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Arousal as measured by FSFI questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Course of BNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Course of NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Course of hsTnT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in Quality of Life (QOL) From Baseline
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in MMRC Scale From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in FEV1 From Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: number of days without a bipolar mood episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical global impression for bipolar disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of oculomotor disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Percentage of Participants Achieving Serotype-specific Pneumococcal IgG Antibody Level >= 0.35 mcg/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Geometric Mean Concentration (GMC) of Serotype-specific Pneumococcal IgG Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Participants Achieving Predefined Antibody Levels for Diphtheria, Tetanus, and Pertussis Antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality of Life (KDQOL36)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in Hb Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Methadone dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Differences in thrombin generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Differences in fibrin clot properties
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Difference in neurocognition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fatty acid (%) change in blood plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Fatty acid change (%) in blood plasma phospholipids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change from baseline of the mean Major symptom complex score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Center of Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Combined number of hospitalizations and emergency department presentations
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Repetition of deliberate self-harm (DSH)
Endpoint domain: Adverse events/effects
Primary endpoint: Immunogenicity measured by GMR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Surgical time per technical phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in serum phosphorus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Difference in Percentage of Leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Measured Steps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in daily physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Uncorrected Near Vision Acuity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Patients Recovered Cognitively
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cancer detection rate of the seropositive group
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Prevalence of serum antibodies to human papillomavirus (HPV)16 E antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of patients with complete chimerism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacodynamic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of complete hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Changes in fasting blood LDL cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Symptom Management at the End of Life for Dementia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: arterial and mixed venous blood gases
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pulmonary vascular pressures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional Independence Measure (FIM score)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Gestational Sac Expulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Need for Additional Medical or Surgical Intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Major Pathological Response (MPR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of in-procedure QFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consumption of opioids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: AUC (area under curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oral health status (Modified Gingival Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in oral health status (Community Periodontal Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in UPDRS II + III total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Pain inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of a new malignancy at 5 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of a new malignancy at 10 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of a new malignancy at 15 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Percentages of Events After Index Visit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Regional Lung Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in Regional Heart Function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Relating RT-Induced Changes in Regional injury to Global Cardiopulmonary Changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in trust in science
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Believability profiles
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Preventive behavioral intentions
Endpoint domain: Life impact
Endpoint subdomain: Behavioral outcomes
Primary endpoint: 10-Meter walk (10 MWT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 9 Hole Peg Test (9HPT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Arterial pH at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PaO2/FiO2 ratio at 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Number of adverse events (AEs) that are ophthalmologic, neurologic, infectious or hematologic
Endpoint domain: Adverse events/effects
Primary endpoint: Number of new diagnoses of an immune-mediated disorder
Endpoint domain: Adverse events/effects
Primary endpoint: Incidents of new cancer, irrespective of prior history
Endpoint domain: Adverse events/effects
Primary endpoint: Time to first hemoglobin response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rise in Systolic Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Liver Iron Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cough count
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Fetal Weight at Birth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Drop comfort upon instillation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: volume (ml) of sperm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Count (million / ml) of spermatozoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mobility (%) and mobility type of spermatozoa
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of stroke or systemic embolism
Endpoint domain: Mortality/survival
Primary endpoint: Any major or clinically-relevant nonmajor bleed resulting in hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Nonresponsive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Migraine attacks frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of subjects experiencing adverse events related to drug-induced changes in hemodynamic function
Endpoint domain: Adverse events/effects
Primary endpoint: Procedural related major complications
Endpoint domain: Adverse events/effects
Primary endpoint: Time from diagnosis to intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Knee Abduction Moment - Cycling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Knee Abduction Moment - Gait
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cognitive, Language and Motor Composite Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Maternal Cognitive Function Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Quality of life: QOL-AD score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Time to Occurrence of Selected Prismaflex® System Alarms/Conditions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinically desired breast volume maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Adenomatous Polyp Detection Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Coronary artery disease detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parietal complications after surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Change in abdominal fat mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: American Society for Elbow and Shoulder Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Simple Shoulder Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PROMIS Global 10
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in QTcF intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Stages of Recovery Scale (SRS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cure 30 days following FMT treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of change in VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Difference in attendance
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Abnormal vital signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numerical pain recording scale
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Pain of dysmenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of driving under the influence of alcohol
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Survival of indirect composite restorations
Endpoint domain: Mortality/survival
Primary endpoint: Measurable Disease Response Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: blood levels of lithium or sertraline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluctuations in symptom severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: retinal thickness of the most significant schisis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain immediately after maximum incentive spirometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cortisol-awakening-response (CAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Stress questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Circadian Status (Free-running Versus Entrained)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Melatonin Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Change in High-density Lipoprotein Cholesterol (HDL-C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Objective Response (Complete Response (CR) or Partial Response (PR))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in baseline mean Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in baseline mean urinary output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Percentage of Participants With Adverse Events (AE) Related to Treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Overall Survival Rate at 12 Months (OS12)
Endpoint domain: Mortality/survival
Primary endpoint: Bronchospasmolytic effect (FEV1 increase)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in patient knowledge of systemic corticosteroids
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: postoperative bleeding volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hematocrit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Participant and Instructor Rating of experience, satisfaction, and feasibility of program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Montreal Cognitive Assessment (global cognitive function)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Disease progression to score 4 and below on COVID scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma/Serum Concentration (Cmax) Of ABBV-CLS-579
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Objective Response Rate (ORR) Of ABBV-CLS-579 And PD-1 Targeting Agent
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recommended Expansion Dose and/or Maximum Tolerated Dose of ABBV-CLS-579
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of dehydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Costs and cost-variability
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: diaphragmatic work of breathing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quantitative change of lung volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total Nasal Symptom Score (TNSS) Area Under the Curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: in hospital all cause mortality
Endpoint domain: Mortality/survival
Primary endpoint: Overall rate of Serious Adverse Events and serious adverse device effects
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of autistic disorder
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Detected Uptakes on PET Images
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 28 Day Mortality
Endpoint domain: Mortality/survival
Primary endpoint: rate of local recurrence
Endpoint domain: Mortality/survival
Primary endpoint: iPRGC activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Light levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatal or non-fatal symptomatic ICH
Endpoint domain: Mortality/survival
Primary endpoint: Safety of infusion of autologous IgT cells
Endpoint domain: Adverse events/effects
Primary endpoint: Sustained Freedom From Headache Pain 2-48 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained Freedom From Most Bothersome Symptom 2-48 Hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gestational diabetes mellitus (GDM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Refractive errors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ki comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRglu comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVmax comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SUVmax 60/30 comparison
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: snoring intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Women Who Experienced Various Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Women Who Experienced Grade ≥ 3 Adverse Events (AEs) in Step 2
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Infants With Various Adverse Events Following Maternal Vaccination
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Women With a Two-fold or Higher Increase in ELISA-measured IgG PNC Antibody Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Number of Infant Participants With ELISA-measured IgG PNC Antibody Levels ≥ 0.35ug/mL at 8 Weeks of Age
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Consumption of Propofol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Negative predictive value of mpMRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mean Interleukin 15 (IL-15) Expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adequate Relief of Global IBS Symptoms
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: ICP evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Bronchial dysplasia number and grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Moorong Self-Efficacy Scale (MSES) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional dependence
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reduction of opioid analgesic dosage
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Change in Anti-MUC1 Immunoglobulin G (IgG) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Area Under the Curve of Plasma Glucose Concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Curve of Glucose Infusion Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ability to predict colorectal polyp histology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patient enrollment in outpatient treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Patient retention in outpatient treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Residual plasma concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Signs and symptoms of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes